Jung, Jae Woo <br/><br/>
An Activin A/BMP2 chimera, AB215, blocks estrogen signaling via induction of ID proteins in breast cancer cells.  [electronic resource] 

 -  BMC cancer  Jul 2014 
 - 549 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/1471-2407-14-549  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activins--pharmacology<br/>Bone Morphogenetic Protein 2--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Estrogen Receptor alpha--metabolism<br/>Female<br/>Humans<br/>Inhibitor of Differentiation Proteins--genetics<br/>MCF-7 Cells<br/>Neoplasm Transplantation<br/>Recombinant Fusion Proteins--pharmacokinetics<br/>Signal Transduction--drug effects<br/>Tamoxifen--therapeutic use<br/>Xenograft Model Antitumor Assays